12934 related articles for article (PubMed ID: 11261621)
21. Sentinel node mapping in colon carcinoma: in-vivo versus ex-vivo approach.
Tuech JJ; Pessaux P; Di Fiore F; Nitu V; Lefebure B; Colson A; Michot F
Eur J Surg Oncol; 2006 Mar; 32(2):158-61. PubMed ID: 16376515
[TBL] [Abstract][Full Text] [Related]
22. Lymph node mapping and sentinel node detection in patients with cervical carcinoma: a 2-year experience.
Di Stefano AB; Acquaviva G; Garozzo G; Barbic M; Cvjeticanin B; Meglic L; Kobal B; Rakar S
Gynecol Oncol; 2005 Dec; 99(3):671-9. PubMed ID: 16129476
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo lymphatic mapping: a technique to improve pathologic staging in colorectal cancer.
Broderick-Villa G; Amr D; Haigh PI; O'Connell TX; Danial T; Difronzo LA
Am Surg; 2004 Nov; 70(11):937-41. PubMed ID: 15586501
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node mapping in colon cancer: current status.
de Haas RJ; Wicherts DA; Hobbelink MG; Borel Rinkes IH; Schipper ME; van der Zee JA; van Hillegersberg R
Ann Surg Oncol; 2007 Mar; 14(3):1070-80. PubMed ID: 17206482
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node (SLN) procedure with patent V blue dye in 153 patients with papillary thyroid carcinoma (PTC): is it an accurate staging method?
Rubello D; Nanni C; Merante Boschin I; Toniato A; Piotto A; Rampin L; Mariani G; Al-Nahhas A; Pelizzo MR
J Exp Clin Cancer Res; 2006 Dec; 25(4):483-6. PubMed ID: 17310837
[TBL] [Abstract][Full Text] [Related]
26. Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach.
Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R
Ann Surg; 2009 Apr; 249(4):602-7. PubMed ID: 19300229
[TBL] [Abstract][Full Text] [Related]
27. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
28. Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms.
Bilchik AJ; Saha S; Tsioulias GJ; Wood TF; Morton DL
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):82S-85S. PubMed ID: 11599909
[TBL] [Abstract][Full Text] [Related]
29. Sentinel node mapping does not improve staging of lymph node metastasis in colonic cancer.
Faerden AE; Sjo OH; Andersen SN; Hauglann B; Nazir N; Gravdehaug B; Moberg I; Svinland A; Nesbakken A; Bakka A
Dis Colon Rectum; 2008 Jun; 51(6):891-6. PubMed ID: 18259817
[TBL] [Abstract][Full Text] [Related]
30. Validation of ex vivo lymphatic mapping in hematoxylin-eosin node-negative carcinoma of the colon and rectum.
Wong JH; Johnson DS; Namiki T; Tauchi-Nishi P
Ann Surg Oncol; 2004 Aug; 11(8):772-7. PubMed ID: 15249341
[TBL] [Abstract][Full Text] [Related]
31. Clinical value of sentinel node mapping in carcinoma of the colon.
Retter SM; Herrmann G; Schiedeck TH
Colorectal Dis; 2011 Aug; 13(8):855-9. PubMed ID: 20456461
[TBL] [Abstract][Full Text] [Related]
32. RT-PCR and immunohistochemical evaluation of sentinel lymph nodes after in vivo mapping with Patent Blue V in colon cancer patients.
Kelder W; van den Berg A; van der Leij J; Bleeker W; Tiebosch AT; Grond JK; Baas PC; Plukker JT
Scand J Gastroenterol; 2006 Sep; 41(9):1073-8. PubMed ID: 16938721
[TBL] [Abstract][Full Text] [Related]
33. Predictive model of outcome of targeted nodal assessment in colorectal cancer.
Nissan A; Protic M; Bilchik A; Eberhardt J; Peoples GE; Stojadinovic A
Ann Surg; 2010 Feb; 251(2):265-74. PubMed ID: 20054276
[TBL] [Abstract][Full Text] [Related]
34. Validation of sentinel node mapping in patients with colon cancer.
Paramo JC; Summerall J; Poppiti R; Mesko TW
Ann Surg Oncol; 2002 Jul; 9(6):550-4. PubMed ID: 12095970
[TBL] [Abstract][Full Text] [Related]
35. Sentinel lymph node mapping for adenocarcinoma of the colon does not improve staging accuracy.
Read TE; Fleshman JW; Caushaj PF
Dis Colon Rectum; 2005 Jan; 48(1):80-5. PubMed ID: 15690662
[TBL] [Abstract][Full Text] [Related]
36. Lymph node evaluation in early-stage colon cancer.
Govindarajan A; Baxter NN
Clin Colorectal Cancer; 2008 Jul; 7(4):240-6. PubMed ID: 18650192
[TBL] [Abstract][Full Text] [Related]
37. Intraoperative sentinel lymph node mapping in patients with colon cancer.
Paramo JC; Summerall J; Wilson C; Cabral A; Willis I; Wodnicki H; Poppiti R; Mesko TW
Am J Surg; 2001 Jul; 182(1):40-3. PubMed ID: 11532413
[TBL] [Abstract][Full Text] [Related]
38. Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial.
Weixler B; Rickenbacher A; Raptis DA; Viehl CT; Guller U; Rueff J; Zettl A; Zuber M
World J Surg; 2017 Sep; 41(9):2378-2386. PubMed ID: 28508233
[TBL] [Abstract][Full Text] [Related]
39. [The intraoperative study of the sentinel lymph node was made possible through molecular analysis: a new concept and new applications for colon cancer?].
Coget J; Pocard M
Bull Cancer; 2014 Apr; 101(4):364-7. PubMed ID: 24793628
[TBL] [Abstract][Full Text] [Related]
40. Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients.
Weixler B; Warschkow R; Zettl A; Riehle HM; Guller U; Viehl CT; Zuber M
World J Surg; 2015 Oct; 39(10):2583-9. PubMed ID: 26154574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
